Cargando…
Phase I trials of antitumour agents: fundamental concepts
Phase I trials are an important step in the development of new drugs. Because of the advancing knowledge of cancer’s molecular biology, these trials offer an important platform for the development of new agents and also for patient treatment. Therefore, comprehension of their peculiar terminology an...
Autores principales: | Toloi, Diego de Araujo, Jardim, Denis Leonardo Fontes, Hoff, Paulo Marcelo Gehm, Riechelmann, Rachel Simões Pimenta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335968/ https://www.ncbi.nlm.nih.gov/pubmed/25729414 http://dx.doi.org/10.3332/ecancer.2015.501 |
Ejemplares similares
-
Living better or living longer? Perceptions of patients and health care professionals in oncology
por: de Araujo Toloi, Diego, et al.
Publicado: (2015) -
TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias
por: Asprino, Paula Fontes, et al.
Publicado: (2017) -
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022) -
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022) -
ICESP, a research hub within a total cancer care center
por: Chammas, Roger, et al.
Publicado: (2019)